799-1919971-7/10003/1

Logos Pharma — FEI 3011433465

Refusal Details

Date
February 4, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61PCY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
Charges
75